Aminopeptidase N
Aminopeptidase N (APN), also known as CD13, is an enzyme that in humans is encoded by the ANPEP gene. APN is a type II transmembrane protein and a zinc-binding enzyme that catalyzes the cleavage of amino acids from the amino terminus of protein or peptide substrates. This enzyme plays a key role in the final digestion of peptides generated from hydrolysis of proteins by gastric and pancreatic proteases. Moreover, aminopeptidase N has been identified as a crucial enzyme in the process of angiogenesis, the growth of blood vessels from pre-existing vasculature, and is also involved in various cellular processes including proliferation, migration, and survival.
Function[edit | edit source]
Aminopeptidase N is widely expressed in various tissues, including the small intestine, kidney, liver, and lungs. It is found on the surface of epithelial cells lining the intestines where it functions in the final stages of digestion of proteins to amino acids. Beyond its role in digestion, APN/CD13 is implicated in several biological processes. It is involved in the regulation of blood pressure through its role in the renin-angiotensin system, where it degrades angiotensin III to angiotensin IV. Additionally, APN has been shown to play a role in tumor cell invasion and metastasis, making it a potential target for cancer therapy.
Clinical Significance[edit | edit source]
The expression of aminopeptidase N is upregulated in various types of cancers, including leukemia, colorectal cancer, and lung cancer. Its role in tumor growth, angiogenesis, and metastasis has led to the development of inhibitors targeting APN as potential anticancer therapies. Furthermore, due to its involvement in the degradation of bioactive peptides, APN is also a target for the treatment of hypertension and other cardiovascular diseases.
Genetic[edit | edit source]
The ANPEP gene, which encodes the aminopeptidase N enzyme, is located on chromosome 15q26.2 in humans. Mutations in this gene have been associated with various diseases, although the specific conditions linked to ANPEP mutations are not well characterized.
See Also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
